Lobbying
Altria CFO Reiterates Company’s U.S. Cannabis Plans
Altria, maker of Marlboro, is “excited about the U.S. opportunity for our investment in Cronos,” a Canadian cannabis company, the company’s CFO said during a consumer conference Wednesday.
Altria, Maker of Marlboro Cigarettes, Is Lobbying on Cannabis Sales in Virginia
Altria, parent company of Philip Morris USA, recently registered to lobby on cannabis in Virginia, where a legalization bill backed by the governor is sailing through the legislature.
Who Lobbied on the MORE Act?
The MORE Act, which would remove cannabis from the Controlled Substances Act, is up for a full House vote on Friday.
Who Is Newly Lobbying On Cannabis?
At the federal level, more than a dozen entities have begun to lobby on cannabis-related issues, including hemp and CBD, or adjusted their focus.
National Cannabis Lobbying Falls, Again
The amount of money that cannabis-focused entities spent on cannabis lobbying at the federal level fell for the third quarter in a row, following an unprecedented rise in 2019.
Will Trulieve Dominate Cannabis in the South?
Trulieve is responsible for half of all cannabis product sales in Florida. According to state lobbying disclosures, the company is watching Florida’s neighbors, too.
Canopy Growth’s US Lobbying Footprint Expands
One of the world’s largest cannabis companies is now lobbying in at least a half dozen states.
Today, Texas’ Cannabis Industry Is Tiny. Cannabis Giants See Potential.
Cannabis Wire has found that major cannabis companies, like Canopy Growth, are registered to lobby.
Who Is Now Lobbying on Cannabis, CBD, and Hemp?
Altria and Anheuser-Busch, previously lobbying on hemp and cannabis respectively, have now specified CBD as an area of interest.
Cannabis Lobbying Spend Continues to Decrease
After reaching new highs in 2019, lobbying by cannabis companies and groups continues to fall in 2020.
Lobbying: GW Pharmaceuticals Extends Its Reach
The company’s subsidiary donates big to attorneys general groups of both parties.
Federal Lobbying on Cannabis Dipped in the First Part of 2020
Compared to the last quarter, spending on cannabis-related issues is down somewhat, though some entities are pushing for coronavirus relief.
Lobbying: Anti-Cannabis Efforts Ramped Up at the End of 2019
Two groups, including the campaign arm of The Heritage Foundation, joined an anti-cannabis veteran to oppose cannabis legislation in Congress.
The Cannabis Industry Spent More On Lobbying Than Ever Before in 2019. What’s Next is Unclear.
Companies and organizations spent nearly $11 million on federal lobbying alone, vastly outpacing previous years. But given the coronavirus, 2020 is a mystery.
Charlotte’s Web to Lobby on Florida’s Hemp Rollout
One of the largest and oldest CBD companies hopes to shape the state’s hemp industry, expected to be among the top in the nation.
Another Big Ag Company Sets Its Sights on Hemp
Syngenta, which rejected an acquisition by Monsanto in 2015, is the latest major agriculture company monitoring the newly-legal market.
